Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,158 | -21,826 | -21,325 | -25,848 | 18,245 |
| Depreciation Amortization | 36,552 | 33,483 | 30,572 | 28,329 | 9,312 |
| Income taxes - deferred | -6,228 | -5,321 | -5,437 | -770 | 1,401 |
| Accounts receivable | 6,876 | 604 | -1,307 | -5,217 | -12,643 |
| Accounts payable and accrued liabilities | 3,078 | 3,095 | 1,689 | 615 | -4,372 |
| Other Working Capital | 13,601 | -368 | -11,871 | -20,381 | -14,125 |
| Other Operating Activity | 34,626 | 27,749 | 22,464 | 17,236 | 67,048 |
| Operating Cash Flow | $64,347 | $37,416 | $14,785 | $-6,036 | $64,866 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 486 | -16,106 | -12,532 | -12,131 | -21,829 |
| PPE Investments | -35,976 | -28,797 | -13,982 | -4,731 | -28,308 |
| Net Acquisitions | -18,727 | -18,726 | -18,726 | N/A | N/A |
| Purchase Of Investment | -5,569 | -5,569 | -5,569 | -5,569 | N/A |
| Sale Of Investment | 1,533 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,114 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-60,367 | $-69,198 | $-50,809 | $-22,431 | $-50,137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 10,000 |
| Debt Repayment | -115 | -88 | -57 | -26 | -97 |
| Common Stock Issued | 4,622 | 1,816 | 1,519 | 988 | 4,998 |
| Other Financing Activity | -11,467 | -4,099 | -2,914 | -2,515 | -8,762 |
| Financing Cash Flow | $-6,960 | $-2,371 | $-1,452 | $-1,553 | $6,139 |
| Beginning Cash Position | 119,709 | 119,709 | 119,709 | 119,709 | 98,841 |
| End Cash Position | 116,729 | 85,556 | 82,233 | 89,689 | 119,709 |
| Net Cash Flow | $-2,980 | $-34,153 | $-37,476 | $-30,020 | $20,868 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,347 | 37,416 | 14,785 | -6,036 | 64,866 |
| Capital Expenditure | -36,021 | -28,837 | -14,003 | -4,740 | -28,326 |
| Free Cash Flow | 28,326 | 8,579 | 782 | -10,776 | 36,540 |